Table 5, Comparative Treatment Response Rates for HCV infection - Screening for Hepatitis C Virus Infection

Warning: The NCBI web site requires JavaScript to function. more...

Treatment	Sustained Virologic Response	Source
Placebo	<2%	Poynard, 1996*
Interferon monotherapy	6–16%	Poynard, 1996*
		Gebo, 2002*
		Kjaergard, 2000*
		Shepherd, 2000*
Interferon plus Ribavirin	33–41%	Gebo, 2002*
		Kjaergard, 2000*
		Shepherd, 2000*
Pegylated Interferon alone	25–39%	Heathcote, 2000
		Lindsay, 2001
		Reddy, 2001
		Zeuzem, 2000
Pegylated Interferon plus Ribavirin	54–60%	Fried, 2002
		Glue, 2000
		Manns, 2001

Screening for Hepatitis C Virus Infection [Internet].

Systematic Evidence Reviews, No. 24.

Chou R, Clark E, Helfand M.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.